Brinda Balasubramanian

8PUBLICATIONS
25CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 24, 2024
Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation.

Kyaw Zwar Myint, Brinda Balasubramanian, Simran Venkatraman

|Dec 19, 2023
Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells.

Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman

|May 13, 2023
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma.

Brinda Balasubramanian, Kiren Yacqub-Usman, Simran Venkatraman

|Jul 27, 2022
In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma.

Brinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint

|Feb 25, 2022
Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach.

Simran Venkatraman, Brinda Balasubramanian, Pisut Pongchaikul

Pageof 2